Aligos Therapeutics, Inc.
NASDAQ:ALGS
9.83 (USD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|
Operating Activities: | ||||||
Net Income
| -87.679 | -96.046 | -128.332 | -108.543 | -52.264 | -13.933 |
Depreciation & Amortization
| 3.069 | 3.675 | 3.778 | 3.325 | 2.299 | 1.291 |
Deferred Income Tax
| 2.219 | 0 | 0 | 0.53 | 0 | -0.11 |
Stock Based Compensation
| 12.652 | 14.693 | 13.457 | 2.975 | 0.752 | 0.179 |
Change In Working Capital
| -9.525 | -1.552 | -4.651 | 16.063 | 3.671 | 4.885 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| -2.219 | 1.722 | -0.313 | -0.13 | 0.385 | 2.977 |
Other Working Capital
| -7.306 | -3.274 | -4.338 | 16.193 | 3.286 | 1.908 |
Other Non Cash Items
| 0.267 | -0.159 | 0.086 | 11.387 | -1.225 | 1.639 |
Operating Cash Flow
| -78.997 | -79.389 | -115.662 | -74.263 | -46.767 | -6.049 |
Investing Activities: | ||||||
Investments In Property Plant And Equipment
| -0.019 | -0.943 | -0.892 | -2.064 | -2.786 | -2.516 |
Acquisitions Net
| 0 | 25.35 | -3.914 | -34.819 | -9.577 | 0 |
Purchases Of Investments
| -0.011 | -104.265 | -19.086 | -45.281 | -70.423 | -66.773 |
Sales Maturities Of Investments
| 45.011 | 78.915 | 23 | 80.1 | 80 | 0 |
Other Investing Activites
| 0 | -25.35 | 3.914 | 34.819 | 9.577 | -72.843 |
Investing Cash Flow
| 44.981 | -26.293 | 3.022 | 32.755 | 6.791 | -69.289 |
Financing Activities: | ||||||
Debt Repayment
| -0.096 | -0.061 | -0.079 | -0.058 | -0.043 | -0.001 |
Common Stock Issued
| 88.424 | 0.02 | 78.584 | 155.542 | 85.575 | 0.002 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 70.981 | 0.205 | 0.172 | 36.864 | -0.043 | 99.884 |
Financing Cash Flow
| 88.328 | 0.164 | 78.677 | 192.348 | 85.532 | 99.885 |
Other Information: | ||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 54.312 | -105.518 | -33.963 | 150.84 | 45.556 | 24.547 |
Cash At End Of Period
| 135.774 | 81.462 | 186.98 | 220.943 | 70.103 | 24.547 |